PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsjoint diseases
MeSH D007592 - joint diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009140:Musculoskeletal diseases
0 Companies
0 Drugs
Success rate
D007592: 
Joint diseases
$
Success rate
D000070657:Crystal arthropathies
0 Companies
0 Drugs
Success rate
D000844:Ankylosis
0 Companies
0 Drugs
Success rate
D001168:Arthritis
$
Success rate
D001176:Arthrogryposis
0 Companies
0 Drugs
Success rate
D001177:Neurogenic arthropathy
0 Companies
0 Drugs
Success rate
D002062:Bursitis
D003286:Contracture
0 Companies
0 Drugs
Success rate
D004204:Joint dislocations
0 Companies
0 Drugs
Success rate
D006395:Hemarthrosis
0 Companies
0 Drugs
Success rate
D006833:Hydrarthrosis
0 Companies
0 Drugs
Success rate
D007593:Joint instability
0 Companies
0 Drugs
Success rate
D007594:Joint loose bodies
0 Companies
0 Drugs
Success rate
D009261:Nail-patella syndrome
0 Companies
0 Drugs
Success rate
D010004:Primary hypertrophic osteoarthropathy
0 Companies
0 Drugs
Success rate
D010005:Secondary hypertrophic osteoarthropathy
0 Companies
0 Drugs
Success rate
D013585:Synovitis
D013705:Temporomandibular joint disorders
0 Companies
0 Drugs
Success rate
D015838:Synovial chondromatosis
0 Companies
0 Drugs
Success rate
D016916:Acquired joint deformities
0 Companies
0 Drugs
Success rate
D018771:Arthralgia
0 Companies
0 Drugs
Success rate
D019534:Shoulder impingement syndrome
0 Companies
0 Drugs
Success rate
D020857:Hallux limitus
0 Companies
0 Drugs
Success rate
D020859:Hallux rigidus
0 Companies
0 Drugs
Success rate
D037061:Metatarsalgia
0 Companies
0 Drugs
Success rate
D046788:Patellofemoral pain syndrome
0 Companies
0 Drugs
Success rate
D057925:Femoracetabular impingement
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
14%
1/7
Phase 3
50%
2/4
Approved: 2Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use